SAMA (Short-Acting Muscarinic Antagonists) Bronchodilator Pharmacology episode artwork

EPISODE · Jan 27, 2026 · 24 MIN

SAMA (Short-Acting Muscarinic Antagonists) Bronchodilator Pharmacology

from This Is Why with Dr. Busti · host Anthony Busti, MD, PharmD, MSc, FNLA, FAHA

Short-acting muscarinic antagonists (SAMAs) are a core bronchodilator drug class you’ll see constantly in COPD care. In this lecture from This is Why, Dr. Busti will learn about short-acting muscarinic antagonists (SAMAs) are a core bronchodilator drug class you’ll see constantly in COPD care—and on exams like the NCLEX. In this lecture, you’ll learn exactly how SAMAs work, when to use them, and what safety pearls can help you avoid common clinical pitfalls in COPD.You’ll learn how to:Mechanism of action: muscarinic (M3) blockade → decreased bronchoconstrictionKey drug: ipratropium (Atrovent)Common combinations: ipratropium/albuterol (DuoNeb, Combivent)Clinical uses: COPD maintenance/symptom relief, COPD exacerbation support, select asthma situations (often as add-on therapy in acute care)Routes & devices: MDI vs nebulized treatments, dosing frequency, and practical inhaler/neb pearlsAdverse effects & warnings: dry mouth, cough, urinary retention (BPH), blurry vision/precipitating angle-closure symptoms if sprayed into eyes, and other anticholinergic considerationsHigh-yield comparisons: SAMA vs LAMA (where tiotropium and other long-acting agents fit)The goal = make medical education easy and clinically relevant.Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/sama-short-acting-muscarinic-antagonist-ipratropium-bronchodilatorGet more with a free membership at https://www.thisiswhy.health/Access free downloads from our videos Access deep dive content from Dr. BustiOrganize content via playlists & collectionsJoin live Q&AReceive member newslettersCoupons & discounts for exam prep resourcesIf this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!Disclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.

Episode metadata supplied by the publisher feed · Published Jan 27, 2026

Embed this episode

Short-acting muscarinic antagonists (SAMAs) are a core bronchodilator drug class you’ll see constantly in COPD care. In this lecture from This is Why, Dr. Busti will learn about short-acting muscarinic antagonists (SAMAs) are a core bronchodilator drug class you’ll see constantly in COPD care—and on exams like the NCLEX. In this lecture, you’ll learn exactly how SAMAs work, when to use them, and what safety pearls can help you avoid common clinical pitfalls in COPD. You’ll learn how to: Mecha...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

SAMA (Short-Acting Muscarinic Antagonists) Bronchodilator Pharmacology

0:00 24:10

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of This Is Why with Dr. Busti?

This episode is 24 minutes long.

When was this This Is Why with Dr. Busti episode published?

This episode was published on January 27, 2026.

Can I download this This Is Why with Dr. Busti episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!